Clin2
NCT06779149Possibly a fitRecruiting

Comparing therapy and medication for chronic insomnia

Insomnia Disorder

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial compares two treatments for chronic insomnia: cognitive behavioral therapy (CBT-I) and a medication called lemborexant. It aims to find which works better for different types of insomnia. You may qualify if you have ongoing trouble sleeping and are not taking other sleep aids.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
90 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have chronic insomnia that significantly affects your daytime life.
  • You are not currently taking sleep medications more than 2 nights per week.
  • You do not have another sleep disorder like sleep apnea or restless legs.
  • You are able to read and understand English or French and use a smartphone, tablet, or computer with internet.
  • You do not work night shifts more than 5 nights per month and do not regularly drink heavily.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06767137Recruiting
Comparing two therapies for insomnia

This study compares two types of talk therapy — BRT (a brief version) and CBT-I (the standard approach) — to see which works better for people with insomnia. You would attend sessions and learn techniques to improve your sleep.

Bern, Canton of Bern
NCT07542756Recruiting· Phase 4
Testing Common Sleep Medications for Insomnia

This study compares how well different over-the-counter and prescription sleep medications work for insomnia. Researchers will guide you through trying medications one at a time to find what works best for your sleep problems.

Philadelphia, Pennsylvania
NCT06823752Recruiting· Phase 2
Insomnia medication to reduce brain damage markers in adults

This trial tests whether a medication that blocks brain chemicals involved in wakefulness can help reduce markers of nerve damage in people with insomnia. It is for adults aged 40–65 with chronic insomnia, and it aims to see if improving sleep may protect brain health.

Macquarie Park, New South Wales
NCT06633263Enrolling by invitation
Combined therapy for depression and insomnia

This trial tests a combination of two behavioral therapies to improve both depression symptoms and sleep problems. It may help you if you have moderate depression and insomnia and can participate in French-language sessions.

Liège
NCT07392177Recruiting· Phase 2
Understanding the brain's role in insomnia

This trial tests whether a part of the brain called the locus coeruleus is involved in insomnia. It involves sleep questionnaires and possibly brain imaging to understand your sleep problems better.

Macquarie Park, New South Wales
NCT06727916Not yet recruiting
Brief therapy for chronic insomnia patients on medication

This study tests if adding a short behavioral therapy program helps people with chronic insomnia who are already taking sleep medication. It looks at whether this combination improves sleep and is cost-effective.

Hear when a new Insomnia Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.